The shares of Harmony Gold Mining Company Limited (NYSE:HMY) has been pegged with a rating of Overweight by JP Morgan in its latest research note that was published on February 21st, 2019. JP Morgan wasn’t the only research firm that published a report of Harmony Gold Mining Company Limited, with other equities research analysts also giving their opinion on the stock. Macquarie advised investors in its research note published on August 28th, 2018, to Underperform the HMY stock. The stock had earned Neutral rating from BofA/Merrill when it published its report on October 20th, 2017. The stock was given Sell rating by Deutsche Bank in its report released on October 13th, 2017. Deutsche Bank was of a view that HMY is Sell in its latest report on March 17th, 2017. HSBC Securities thinks that HMY is worth Hold rating. This was contained in the firm’s report on November 11th, 2016.
Amongst the analysts that rated the stock, 0 have recommended investors to sell it, 0 believe it has the potential for further growth, thus rating it as Hold while 1 advised investors to purchase the stock. The consensus currently stands at a Hold while its average price target is $3.19. The price of the stock the last time has raised by 107.72% from its Week high price while it is raised higher than its 52-Week low price. A look at the stock’s other technical shows that its 14-day RSI now stands at 68.20.
The shares of the company dipped by -2.63% during the trading session on Monday, reaching a low of $2.95 while ending the day at $2.96. During the trading session, a total of 15.61 million shares were traded which represents a -110.39% decline from the average session volume which is 7.42M shares. HMY had ended its last session trading at 3.04. Harmony Gold Mining Company Limited currently has a market cap of $1.52B while its P/E earnings growth sits at 0.94, with a beta of -1.35. Harmony Gold Mining Company Limited debt-to-equity ratio currently stands at 0.23, while its quick ratio hovers at 0.80. HMY 52-week low price stands at $1.42 while its 52-week high price is $3.07.
Harmony Gold Mining Company Limited has the potential to record -0.78 EPS for the current fiscal year, according to equities analysts.
Investment analysts at Wells Fargo published a research note on June 5th, 2019 where it informed investors and clients that Medtronic plc (NYSE:MDT) is now rated as Outperform. Macquarie also rated MDT as Downgrade on August 28th, 2018, with its price target of suggesting that MDT could surge by 3.4% from its current share price. Even though the stock has been trading at $101.67/share, analysts expect it to surge higher by -0.51% to reach $104.71/share. It started the day trading at $102.01 and traded between $100.66 and $101.15 throughout the trading session.
A look at its technical shows that MDT’s 50-day SMA is 99.39 while its 200-day SMA stands at 92.45. The stock has a high of $103.95 for the year while the low is $81.66. The company’s P/E ratio currently sits at 29.72, while the P/B ratio is 2.71. At the moment, only of Medtronic plc shares were sold short. The company’s average trading volume currently stands at 4.79M shares, which means that the short-interest ratio is just 1.79 days. Over the past seven days, the company moved, with its shift of 1.65%. Looking further, the stock has raised 15.83% over the past 90 days while it gained 12.89% over the last six months.
The change in the stock’s fortunes has led to several institutional investors altering their holdings of the stock. The Vanguard Group Inc sold more MDT shares, decreasing its portfolio by -0.27% during the last quarter. This move now sees The Vanguard Group Inc selling -294,124 shares in the last quarter, thus it now holds 109,803,595 shares of MDT, with a total valuation of $10,693,772,117. Wellington Management Co LLP meanwhile sold more MDT shares in the recently filed quarter, changing its stake to $6,656,756,383 worth of shares. BlackRock Fund Advisors followed the path by increasing its MDT portfolio by +7.20% in the quarter. This means that BlackRock Fund Advisors bought 4,522,691 shares in the last quarter and now controls 67,365,057 shares of the MDT stock, with the valuation hitting $6,560,682,901.
Similarly, Massachusetts Financial Services increased its Medtronic plc shares by +0.16% during the recently filed quarter. After buying 88,595 shares in the last quarter, the firm now controls 56,935,876 shares of Medtronic plc which are valued at $5,544,984,964. In the same vein, Lazard Asset Management LLC increased its Medtronic plc shares by during the most recent reported quarter. The firm bought 4,935,080 shares during the quarter which increased its stakes to 27,824,976 shares and is now valued at $2,709,874,413. Following these latest developments, around 0.10% of Medtronic plc stocks are owned by institutional investors and hedge funds.